Bank of America’s Dare Bioscience DARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-129
| Closed | -$250 | – | 6011 |
|
|
2025
Q4 | $250 | Sell |
129
-2
| -2% | -$4 | ﹤0.01% | 6664 |
|
|
2025
Q3 | $275 | Buy |
131
+32
| +32% | +$72 | ﹤0.01% | 7682 |
|
|
2025
Q2 | $236 | Buy |
99
+12
| +14% | +$35 | ﹤0.01% | 7811 |
|
|
2025
Q1 | $252 | Buy |
87
+4
| +5% | +$12 | ﹤0.01% | 7642 |
|
|
2024
Q4 | $259 | Hold |
83
| – | – | ﹤0.01% | 7534 |
|
|
2024
Q3 | $269 | Buy |
83
+1
| +1% | +$3 | ﹤0.01% | 7502 |
|
|
2024
Q2 | $330 | Buy |
82
+70
| +583% | +$339 | ﹤0.01% | 7437 |
|
|
2024
Q1 | $72 | Sell |
12
-11
| -48% | -$54 | ﹤0.01% | 7423 |
|
|
2023
Q4 | $85 | Buy |
+23
| New | +$105 | ﹤0.01% | 7429 |
|
|
2023
Q1 | – | Sell |
-17
| Closed | -$166 | – | 7885 |
|
|
2022
Q4 | $166 | Buy |
+17
| New | +$190 | ﹤0.01% | 7582 |
|
|
2022
Q2 | – | Sell |
-2,473
| Closed | -$44K | – | 8080 |
|
|
2022
Q1 | $44K | Buy |
+2,473
| New | +$46.8K | ﹤0.01% | 7222 |
|
|
2021
Q3 | – | Sell |
-193
| Closed | -$4K | – | 8151 |
|
|
2021
Q2 | $4K | Buy |
+193
| New | +$3.3K | ﹤0.01% | 7456 |
|
|
2020
Q1 | – | Sell |
-53
| Closed | -$1K | – | 6910 |
|
|
2019
Q4 | $1K | Sell |
53
-91
| -63% | -$886 | ﹤0.01% | 6955 |
|
|
2019
Q3 | $1K | Buy |
+144
| New | +$1.38K | ﹤0.01% | 7088 |
|
|
2018
Q4 | – | Sell |
-56
| Closed | -$1K | – | 7154 |
|
|
2018
Q3 | $1K | Buy |
+56
| New | +$754 | ﹤0.01% | 7113 |
|
|
2018
Q1 | – | Sell |
-1
| Closed | – | – | 7133 |
|
|
2017
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 7056 |
|
|
2017
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 7082 |
|
|
2017
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 6967 |
|
|
2017
Q1 | $0 | Sell |
1
-57
| -98% | -$8.23K | ﹤0.01% | 7009 |
|
|
2016
Q4 | $5K | Buy |
58
+38
| +190% | +$3.62K | ﹤0.01% | 6694 |
|
|
2016
Q3 | $3K | Sell |
20
-12
| -38% | -$2.69K | ﹤0.01% | 6729 |
|
|
2016
Q2 | $8K | Sell |
32
-89
| -74% | -$28.5K | ﹤0.01% | 6561 |
|
|
2016
Q1 | $40K | Buy |
121
+52
| +75% | +$14.7K | ﹤0.01% | 5865 |
|
|
2015
Q4 | $24K | Buy |
69
+48
| +229% | +$19.9K | ﹤0.01% | 6355 |
|
|
2015
Q3 | $9K | Hold |
21
| – | – | ﹤0.01% | 6595 |
|
|
2015
Q2 | $11K | Buy |
21
+1
| +5% | +$687 | ﹤0.01% | 6552 |
|
|
2015
Q1 | $22K | Buy |
+20
| New | +$19.4K | ﹤0.01% | 6003 |
|
Other funds holding DARE
VCM
VFT
XT
Bank of America's DARE Position: Q1 2026 in Review
Bank of America sold out of Dare Bioscience (DARE) in Q1 2026, closing a stake of 129 shares — an estimated $250 sold.
Bank of America first reported a position in DARE in Q1 2015 and held it in 27 quarters. The position peaked at $44K in Q1 2022. 25 funds tracked by Wall St. Rank hold DARE as of Q1 2026.
- Bank of America reported no remaining Dare Bioscience position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 129 Dare Bioscience shares in Q1 2026, an estimated $250.
- Bank of America first reported a position in Dare Bioscience in Q1 2015 and held it in 27 quarters.
- Bank of America's Dare Bioscience position peaked at $44K in Q1 2022.
- 25 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.